|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismATP7A inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with 4e Therapeutics, Inc.
0 Patents (Medical) associated with 4e Therapeutics, Inc.
100 Deals associated with 4e Therapeutics, Inc.
100 Translational Medicine associated with 4e Therapeutics, Inc.